Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia
Objectives Human papillomavirus (HPV) infection is a major risk factor for cervical cancer. Imiquimod is a topical medication that enhances the immune response to HPV-induced genital warts. This study evaluated…